Theophyllins (et CYP1A2- substrat) farmakokinetik blev ikke påvirket signifikant ved samtidig behandling med duloxetin (60 mg to gange daglig).
The pharmacokinetics of theophylline, a CYP1A2 39 substrate, were not significantly affected by co-administration with duloxetine (60 mg twice daily).